Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus/hepatitis C virus-Reference-Cited by-同舟云学术

Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus/hepatitis C virus

Published:2009-06-19 Issue:4 Volume:50 Page:1056-1063
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Macías Juan,Berenguer Juan,Japón Miguel A.,Girón José A.,Rivero Antonio,López-Cortés Luis F.,Moreno Ana,González-Serrano Mercedes,Iribarren José A.,Ortega Enrique,Miralles Pilar,Mira José A.,Pineda Juan A.

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.23136/fullpdf

Reference27 articles.

1. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis;Graham;Clin Infect Dis,2001

2. Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection;Qurishi;Lancet,2003

3. Survival in patients with HIV infection and viral hepatitis B or C: a cohort study;Bonacini;AIDS,2004

4. Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease;Merchante;AIDS,2006

5. Clinical progression of hepatitis C virus-related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active antiretroviral therapy;Pineda;HEPATOLOGY,2007

Cited by 228 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV and gp120-induced lipid droplets loss in hepatic stellate cells contribute to profibrotic profile;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-04

2. SASLT guidelines: Update in treatment of hepatitis C virus infection, 2024;Saudi Journal of Gastroenterology;2024-01

3. Hepatitis Due to Hepatotropic Viruses;MacSween's Pathology of the Liver;2024

4. Increased Serum Fibroblast Growth Factor 23 Predicts Mortality in People With HIV/HCV Coinfection;JAIDS Journal of Acquired Immune Deficiency Syndromes;2023-11-01

5. A simple, feasible, efficient and safe treatment strategy of sofosbuvir/velpatasvir for chronic HCV/HIV-1 coinfected patients regardless of HCV genotypes: a multicenter, open-label study in China;The Lancet Regional Health - Western Pacific;2023-07